According to a recent LinkedIn post from Araceli Biosciences, the company is actively engaging attendees at the SLAS conference, highlighting interest in its innovation spotlight on 3D imaging of organoid growth at ultra high throughput speeds. The post also references a presentation by Virneliz Fernandez-Vega from the Spicer Lab at The Herbert Wertheim UF Scripps Institute, focused on organoid growth analysis.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Araceli is positioning its Endeavor Ultra platform as a live, high-throughput solution for organoid imaging, with demonstrations taking place at booth #2312. For investors, this visibility at a specialized industry event may support lead generation, partnership discussions, and validation among advanced research users, potentially strengthening the company’s pipeline and competitive stance in high-content imaging and organoid analysis markets.